Researcher examining cultured cells under laboratory conditions

B1 Vitamin Energy Supplement: Why Thiamine Deficiency Drains ATP Production

By Winifred Oduya · Edited by Gus Feld

Listen · Winifred Oduya reads this piece · 2:03

Thiamine. Vitamin B1. The energy vitamin. Except nobody calls it that on a label anymore, because calling something the energy vitamin implies it will give you energy, and that is a promise, and promises require proof, and proof requires a trial, and trials cost money. So instead the bottle says supports healthy energy metabolism.

Supports.

Like a folding chair supports a person sitting down.

The label does not say which metabolic processes, supporting what outcome, or whether your metabolism asked for help. It just supports. Three syllables, zero commitments. It reads like a reference letter written by someone who hired you once, briefly, in 2003, and is now trying to remember your name while the HR department waits on hold.

What Thiamine Actually Does (When Researchers Bother To Measure It)

A 2026 review published in Nutrients examined benfotiamine and alpha-lipoic acid for diabetic peripheral neuropathy. Benfotiamine is thiamine with a fat-soluble sidecar that helps it cross cell membranes, which is a polite way of saying we strapped a lipid to it so the body might actually absorb the damn thing. The paper walked through the mechanism in detail: thiamine activates an enzyme called transketolase, which diverts glycolytic intermediates away from pathways that form advanced glycation end products and reactive oxygen species, and toward the pentose phosphate pathway and ATP energy production. That means it keeps sugar breakdown from turning into cellular garbage and pushes it toward making energy instead.

The review noted that benfotiamine has a strong biochemical rationale but that clinical evidence remains limited to short-duration, symptom-based studies with no large-scale, long-term trials demonstrating structural nerve regeneration or definitive disease-modifying effects. Translation: we know what it does in a test tube, we have questionnaires showing people feel better, and we have no proof it rebuilt a single nerve fiber.

Which is not the same as saying it does nothing. It is saying we measured the wrong thing, or not enough of the right thing, or we stopped measuring too soon.

Thiamine powder being ground in mortar with vitamin supplements

B1 Deficiency Fatigue: When The Vitamin Runs Out And Nobody Notices

A 2026 study in Applied and Environmental Microbiology exposed broiler chickens to low and high doses of agricultural chemical mixtures and microplastics for 49 days. Untargeted metabolomics revealed distinct metabolic reprogramming: chemical mixtures modulated pathways linked to pyruvate and thiamine metabolism and other cofactor-dependent processes, shifting from oxidative, biosynthetically intensive metabolism toward glycolysis and fermentation. Microplastic fibers selectively suppressed oxidative and cofactor pathways, indicating what the researchers called a simplified, maintenance-oriented energy state.

The chickens had no intestinal damage. No lesions. No visible pathology. Just quieter mitochondria and a shift from making energy efficiently to making it the slow, tired way. The paper called this silent dysbiosis, which is a polite term for something is broken but the scan came back normal.

A separate 2026 narrative review in Critical Care noted that micronutrient deficiencies are common in ICU patients due to redistribution, pre-existing deficits, and extracorporeal losses. Redistribution means the body moved the nutrient somewhere a blood test cannot see it. Pre-existing deficits means the patient showed up low. Extracorporeal losses means it left through a tube, a filter, or some other piece of equipment with a Latin name. All three sound more medical than we did not replace what we lost, but that is what they mean.

ATP Energy Production Vitamin: The Mechanic Nobody Mentions

The Nutrients review on benfotiamine spelled out transketolase activation and the diversion of glycolytic intermediates away from damaging pathways. That is the actual work. Thiamine does not support your energy. It runs part of the machinery that makes ATP, and when it is missing, that machinery slows down. The body compensates by routing sugar through a slower, less efficient process that makes lactate instead of energy and leaves you tired for reasons a standard blood panel will not catch.

A 2026 paper in The Journal of Biological Chemistry on radiation-induced lung fibrosis found that ionizing radiation upregulated both glycolysis and the pentose phosphate pathway, and that the pentose phosphate pathway was a significant source of lactate production. Blocking glucose-6-phosphate dehydrogenase, an enzyme in that pathway, markedly reduced lactate accumulation. Thiamine works upstream of that same pathway, activating the enzyme that decides where the sugar goes. When thiamine is low, the decision gets made badly.

None of that appears on the bottle. The bottle says supports. The research says runs an enzyme that diverts toxic sugar breakdown products away from your mitochondria. One of those statements would sell B1 vitamin energy supplements. The other would require explaining what a mitochondrion is, and by the time you finish that sentence the customer has bought a different bottle with a picture of a mountain on it.

How Much B1 Vitamin Do I Need Daily (And Why The RDA Was Set In 1968)

The recommended daily intake for thiamine is 1.1 to 1.2 milligrams for adults, a number established decades ago based on preventing a deficiency disease that causes nerve damage and death. That is the floor. The amount that keeps you alive. Not the amount that keeps every enzyme in the transketolase family running at capacity, or the amount that compensates for a diet built around refined flour and shelf-stable carbohydrates that had the thiamine milled out of them and maybe, possibly, sometimes put back.

The Critical Care review recommended structured assessment and supplementation of micronutrients in ICU patients, emphasizing that uniform targets for all patients ignore metabolic phenotyping and biomarker-informed stratification. Outside the ICU, nobody is phenotyping your metabolism. You are eating what you are eating, your thiamine status is whatever it is, and the RDA was last updated when Lyndon Johnson was president.

A 2026 systematic review in the International Journal of Molecular Sciences on folate and the gut microbiome noted that only a minority of gut bacteria possess complete biosynthetic pathways for B vitamins, and most depend on cross-feeding from other taxa. The same principle applies to thiamine: your gut makes some, bacteria use some, and what is left over depends on what you ate, what your microbiome looks like, and whether anything in the last six months disrupted either one.

The label will not tell you any of that. The label will say vitamin B1 for energy, or supports cellular metabolism, or promotes healthy mitochondrial function, all of which are technically true and all of which mean we cannot legally say what this does so we are using the longest possible words to describe the vague area around it.

Thiamine activates transketolase. Transketolase diverts sugar metabolism toward energy production and away from the formation of toxic byproducts. When thiamine is low, ATP production drops, lactate rises, and you feel tired for reasons your doctor will call nonspecific. That is the mechanism. That is what the research shows. And that is why the bottle will never, ever say it.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

  1. The pentose phosphate pathway contributes to excess lactate production in radiation-induced fibroblast to myofibroblast transdifferentiation, The Journal of biological chemistry (2026).
  2. A Systematic Review of Folate and the Human Enteric Microbiome: Biological Mechanisms and Clinical Implications, International journal of molecular sciences (2026).
  3. Current concepts on feeding the critically ill patient: a narrative review, Critical care (London, England) (2026).
  4. Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework, Nutrients (2026).
  5. Vitamins and nutraceuticals in glaucoma research, European journal of ophthalmology (2026).
  6. Exposure to known and emerging groundwater contaminants significantly alters poultry microbiome and metabolome, Applied and environmental microbiology (2026).

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.